Variant report

Variant	esv3418808
Chromosome Location	chr5:16940001-16973969
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:133)
CpG islands
(count:61)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:133 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr5:16970304-16970653	K562	blood:	n/a	n/a
2	BHLHE40	chr5:16970479-16970499	GM12878	blood:	n/a	n/a
3	BHLHE40	chr5:16944415-16944748	K562	blood:	n/a	n/a
4	CEBPB	chr5:16949714-16949929	A549	lung:	n/a	n/a
5	CEBPB	chr5:16959503-16959699	HepG2	liver:	n/a	n/a
6	CEBPB	chr5:16953420-16953784	ECC-1	luminal epithelium:	n/a	n/a
7	CEBPB	chr5:16959481-16959801	IMR90	lung:	n/a	n/a
8	CEBPB	chr5:16959562-16959636	A549	lung:	n/a	n/a
9	CEBPB	chr5:16972221-16972410	HepG2	liver:	n/a	n/a
10	CEBPB	chr5:16961482-16961678	HepG2	liver:	n/a	n/a
11	CEBPB	chr5:16949637-16949818	HepG2	liver:	n/a	n/a
12	CEBPB	chr5:16957860-16958338	IMR90	lung:	n/a	n/a
13	CEBPB	chr5:16972207-16972365	Hela-S3	cervix:	n/a	n/a
14	CHD2	chr5:16953369-16953469	HepG2	liver:	n/a	n/a
15	CTCF	chr5:16953320-16953470	RPTEC	kidney:	n/a	n/a
16	CTCF	chr5:16953240-16953390	Caco-2	colon:	n/a	chr5:16953289-16953302
17	CTCF	chr5:16953259-16953351	MCF-7	breast:	n/a	chr5:16953289-16953302
18	CTCF	chr5:16949620-16949770	A549	lung:	n/a	n/a
19	CTCF	chr5:16958200-16958350	HPAF	blood vessel:	n/a	n/a
20	CTCF	chr5:16950740-16950890	GM12874	blood:	n/a	n/a
21	CTCF	chr5:16955442-16955472	GM10248	blood:	n/a	n/a
22	CTCF	chr5:16953180-16953330	Caco-2	colon:	n/a	chr5:16953289-16953302
23	CTCF	chr5:16971852-16971870	K562	blood:	n/a	n/a
24	CTCF	chr5:16965120-16965270	RPTEC	kidney:	n/a	n/a
25	CTCF	chr5:16965040-16965190	HEK293	kidney:	n/a	n/a
26	CTCF	chr5:16949640-16949790	Hela-S3	cervix:	n/a	n/a
27	E2F4	chr5:16957934-16958221	MCF10A-Er-Src	breast:	n/a	n/a
28	E2F4	chr5:16966957-16967099	MCF10A-Er-Src	breast:	n/a	n/a
29	EP300	chr5:16957877-16958226	SK-N-SH_RA	brain:	n/a	n/a
30	EP300	chr5:16952959-16953786	ECC-1	luminal epithelium:	n/a	n/a
31	EP300	chr5:16953196-16953850	ECC-1	luminal epithelium:	n/a	n/a
32	EP300	chr5:16957650-16958458	SK-N-SH	brain:	n/a	n/a
33	EP300	chr5:16964795-16965431	ECC-1	luminal epithelium:	n/a	n/a
34	EP300	chr5:16957629-16958622	SK-N-SH	brain:	n/a	n/a
35	ESR1	chr5:16964953-16965282	ECC-1	luminal epithelium:	n/a	n/a
36	ESR1	chr5:16964862-16965312	ECC-1	luminal epithelium:	n/a	n/a
37	FOS	chr5:16957958-16958242	MCF10A-Er-Src	breast:	n/a	n/a
38	FOS	chr5:16957934-16958262	MCF10A-Er-Src	breast:	n/a	n/a
39	FOS	chr5:16957916-16958294	MCF10A-Er-Src	breast:	n/a	n/a
40	FOS	chr5:16957832-16958478	HUVEC	blood vessel:	n/a	n/a
41	FOSL2	chr5:16957754-16958459	SK-N-SH	brain:	n/a	n/a
42	FOSL2	chr5:16957919-16958423	SK-N-SH	brain:	n/a	n/a
43	FOXA1	chr5:16953463-16953683	ECC-1	luminal epithelium:	n/a	n/a
44	GATA2	chr5:16957853-16958383	HUVEC	blood vessel:	n/a	n/a
45	GATA3	chr5:16957706-16958478	SK-N-SH	brain:	n/a	n/a
46	GATA3	chr5:16957715-16958530	SK-N-SH	brain:	n/a	n/a
47	HDAC2	chr5:16965007-16965293	K562	blood:	n/a	n/a
48	HNF4A	chr5:16953138-16953367	HepG2	liver:	n/a	n/a
49	JUN	chr5:16957943-16958333	HUVEC	blood vessel:	n/a	n/a
50	JUND	chr5:16957740-16958412	SK-N-SH	brain:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:16940481-16940531	BJ	skin:	n/a
2	chr5:16940481-16940531	GM12892	blood:	n/a
3	chr5:16940481-16940531	SK-N-SH	brain:	n/a
4	chr5:16940481-16940531	SK-N-MC	brain:	n/a
5	chr5:16940481-16940531	HRE	kidney:	n/a
6	chr5:16940481-16940531	AG09319	gingival:	n/a
7	chr5:16940481-16940531	BE2_C	brain:	n/a
8	chr5:16940481-16940531	NB4	blood:	n/a
9	chr5:16940481-16940531	SK-N-SH_RA	brain:	n/a
10	chr5:16940481-16940531	HPAEpiC	pulmonary alveolar:	n/a
11	chr5:16940481-16940531	HIPEpiC	eye:	n/a
12	chr5:16940481-16940531	AG09309	skin:	n/a
13	chr5:16940481-16940531	NH-A	brain:	n/a
14	chr5:16940481-16940531	LNCaP	prostate:	n/a
15	chr5:16940481-16940531	HL-60	blood:	n/a
16	chr5:16940481-16940531	HMEC	breast:	n/a
17	chr5:16940481-16940531	Jurkat	blood:	n/a
18	chr5:16940481-16940531	NHBE	bronchial:	n/a
19	chr5:16940481-16940531	HCT-116	colon:	n/a
20	chr5:16940481-16940531	NT2-D1	testis:	n/a
21	chr5:16940481-16940531	HCM	heart:	n/a
22	chr5:16940481-16940531	U87	brain:	n/a
23	chr5:16940481-16940531	AG10803	skin:	n/a
24	chr5:16940481-16940531	HCF	heart:	n/a
25	chr5:16940481-16940531	HCPEpiC	choroid plexus:	n/a
26	chr5:16940481-16940531	GM06990	blood:	n/a
27	chr5:16940481-16940531	MCF-7	breast:	n/a
28	chr5:16940481-16940531	AG04449	skin:	fetal
29	chr5:16940481-16940531	PrEC	prostate:	n/a
30	chr5:16940481-16940531	HEEpiC	esophagus:	n/a
31	chr5:16940481-16940531	AG04450	lung:	fetal
32	chr5:16940481-16940531	HRPEpiC	eye:	n/a
33	chr5:16940481-16940531	ECC-1	luminal epithelium:	n/a
34	chr5:16940481-16940531	HUVEC	blood vessel:	n/a
35	chr5:16940481-16940531	Hepatocyte	liver:	n/a
36	chr5:16940481-16940531	GM12891	blood:	n/a
37	chr5:16940481-16940531	GM12878	blood:	n/a
38	chr5:16940481-16940531	HNPCEpiC	eye:	n/a
39	chr5:16940481-16940531	RPTEC	kidney:	n/a
40	chr5:16940481-16940531	AoSMC	blood vessel:	n/a
41	chr5:16940481-16940531	GM19239	blood:	n/a
42	chr5:16940481-16940531	Caco-2	colon:	n/a
43	chr5:16940481-16940531	T-47D	breast:	n/a
44	chr5:16940481-16940531	HEK293	kidney:	embryo
45	chr5:16940481-16940531	NHDF-neo	bronchial:	n/a
46	chr5:16940481-16940531	ovcar-3	ovarian:	n/a
47	chr5:16940481-16940531	A549	lung:	n/a
48	chr5:16940481-16940531	HAEpiC	amniotic membrane:	n/a
49	chr5:16940481-16940531	HRCEpiC	kidney:	n/a
50	chr5:16940481-16940531	Hela-S3	cervix:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:16935341..16937147-chr5:16942091..16944719,2	MCF-7	breast:
2	chr5:16735245..16737580-chr5:16952824..16955569,2	MCF-7	breast:
3	chr5:16932890..16934632-chr5:16945745..16947354,2	MCF-7	breast:
4	chr5:16934978..16936561-chr5:16972825..16974430,2	MCF-7	breast:

No data

Variant related genes	Relation type
RNU6-660P	TF binding region
MYO10	TF binding region
RNU6-660P	CpG island
MYO10	CpG island
ENSG00000145555	chromatin interactions

Extended variants
information (count: 1405 )
Associated
traits (count: 91 )

Variant overlapped rSNPs/rCNVs (count:1405 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs546708891	chr5:16940041-16940042	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs79313259	chr5:16940119-16940120	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs532192242	chr5:16940172-16940173	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs550553806	chr5:16940174-16940175	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs570366209	chr5:16940202-16940203	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs55711240	chr5:16940205-16940206	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs537721220	chr5:16940218-16940219	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs372145142	chr5:16940223-16940224	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs183562609	chr5:16940259-16940260	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs535567241	chr5:16940289-16940290	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs567881181	chr5:16940344-16940345	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs534881147	chr5:16940380-16940381	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs553096437	chr5:16940382-16940383	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs201127065	chr5:16940434-16940435	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs188847410	chr5:16940448-16940449	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs147915248	chr5:16940452-16940453	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs556891008	chr5:16940453-16940454	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs117640635	chr5:16940457-16940458	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs575187015	chr5:16940481-16940482	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs542875261	chr5:16940497-16940498	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs575311687	chr5:16940553-16940554	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs193215920	chr5:16940569-16940570	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs573022011	chr5:16940613-16940614	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs3866217	chr5:16940614-16940615	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs564981809	chr5:16940632-16940633	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs557866740	chr5:16940645-16940646	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs543518073	chr5:16940658-16940659	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs183632164	chr5:16940677-16940678	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs186642443	chr5:16940706-16940707	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs76315223	chr5:16940782-16940783	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs191853197	chr5:16940797-16940798	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs549676807	chr5:16940800-16940801	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs567859250	chr5:16940826-16940827	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs535259425	chr5:16940852-16940853	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs573097724	chr5:16940922-16940923	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs546751806	chr5:16940951-16940952	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs571412532	chr5:16941024-16941025	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs140492177	chr5:16941040-16941041	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs183935802	chr5:16941109-16941110	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs575630061	chr5:16941123-16941124	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs540117295	chr5:16941153-16941154	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs189730134	chr5:16941207-16941208	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs554896125	chr5:16941228-16941229	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs573045234	chr5:16941240-16941241	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs540430397	chr5:16941241-16941242	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs13157781	chr5:16941355-16941356	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs565043809	chr5:16941382-16941383	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs181784685	chr5:16941403-16941404	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs372166554	chr5:16941517-16941518	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs377239245	chr5:16941520-16941521	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:91)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21364760	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Melanoma	22183965	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:151 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:16938200-16957600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr5:16939200-16940600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr5:16939200-16940600	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr5:16940000-16940600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr5:16940000-16940600	Enhancers	Fetal Kidney	kidney
6	chr5:16940000-16940800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
7	chr5:16940200-16940400	Flanking Active TSS	Fetal Lung	lung
8	chr5:16940200-16940600	Bivalent/Poised TSS	Fetal Brain Male	brain
9	chr5:16940400-16940600	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr5:16940400-16940600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr5:16940400-16940600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr5:16940400-16940600	Flanking Bivalent TSS/Enh	Brain Angular Gyrus	brain
13	chr5:16940400-16940600	Bivalent Enhancer	Fetal Intestine Small	intestine
14	chr5:16940400-16940600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
15	chr5:16940400-16940600	Bivalent Enhancer	A549	lung
16	chr5:16944600-16945000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr5:16944600-16945000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr5:16945000-16945200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr5:16945200-16946000	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr5:16947600-16948400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
21	chr5:16949400-16950000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr5:16949400-16950000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
23	chr5:16949400-16950200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
24	chr5:16949600-16950000	Enhancers	A549	lung
25	chr5:16952000-16952200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr5:16952200-16953200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
27	chr5:16952600-16953600	Enhancers	Duodenum Mucosa	Duodenum
28	chr5:16952600-16953600	Enhancers	Fetal Intestine Large	intestine
29	chr5:16952600-16953600	Enhancers	Fetal Intestine Small	intestine
30	chr5:16952800-16953600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
31	chr5:16952800-16953600	Enhancers	H1 Cell Line	embryonic stem cell
32	chr5:16952800-16953600	Enhancers	Rectal Mucosa Donor 31	rectum
33	chr5:16953000-16953800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr5:16953200-16953600	Enhancers	ES-I3 Cell Line	embryonic stem cell
35	chr5:16953200-16953600	Enhancers	H9 Cell Line	embryonic stem cell
36	chr5:16953200-16953600	Enhancers	HUES64 Cell Line	embryonic stem cell
37	chr5:16953200-16953600	Enhancers	iPS-15b Cell Line	embryonic stem cell
38	chr5:16953200-16953600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr5:16953200-16953600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr5:16953200-16953600	Enhancers	HepG2	liver
41	chr5:16953200-16953600	Enhancers	Osteobl	bone
42	chr5:16953200-16955200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr5:16953400-16953800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr5:16953400-16957600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr5:16953600-16957600	Weak transcription	Osteobl	bone
46	chr5:16953600-16957800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
47	chr5:16953800-16957600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr5:16953800-16957600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr5:16954800-16955200	Enhancers	Primary hematopoietic stem cells short term culture	blood
50	chr5:16955200-16958000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links